In vivo studies using zebrafish xenografts as a preclinical model34 supported the importance of p38β in AML cells, and confirmed that the combination of CX-4945 and FTY720 is more effective than either treatment alone at reducing tumor growth, as well as impairing cell migration and invasion. Here, MAPK11 is linked to acute myeloid leukemia.